Next Pharmaceuticals recently launched its patented ingredient Citri-Z to address two key aspects of cardiovascular health—inflammation and cholesterol. The proprietary extract is derived 100% from citrus and is standardized to no less than 30% polymethoxyflavones (PMF). In addition to reducing inflammation, the flavones and flavonoids in Citri-Z’s proprietary formula offer cardiovascular protection by reducing total cholesterol and LDL cholesterol, reducing thrombosis, inhibiting macrophage foam cell formation, improving en­dothelial function and helping to maintain healthy blood pressure. Citri-Z can be incorporated into beverages and food, as well as dietary supplements.